Prophylactic carbetocin versus oxytocin following vaginal delivery among women with high risk for postpartum hemorrhage: A before‐and‐after study
Acta Obstetricia et Gynecologica Scandinavica · 2026-05 · 105 (5) · 940-947
DOI: 10.1111/aogs.70180 ↗Kurz gefasst
Vergleichsstudie in der Zeitschrift Acta Obstetricia et Gynecologica Scandinavica, online erschienen am 24.02.2026. Verfasst von Margot Sauvee und 4 weiteren Autor:innen. Beteiligte Einrichtung: Department of Obstetrics and Gynecology, Centre Hospitalier Departemental, La Roche sur Yon, France. Hauptthemen laut MEDLINE: Postpartum Hemorrhage, Oxytocin, Delivery, Obstetric, Oxytocics. Die Arbeit nennt 18 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0).
Abstract (Originalsprache)
Introduction Data with a high level of evidence is lacking on the use of prophylactic uterotonic drug following vaginal delivery to prevent postpartum hemorrhage (PPH) among women who were considered high‐risk for PPH. Our main objective was to compare the effectiveness of prophylactic carbetocin versus oxytocin in preventing PPH after vaginal delivery among women at high risk. Material and Methods We conducted a retrospective before‐and‐after single‐center comparative study, including all high‐risk women after vaginal births. Two consecutive 14‐month periods were compared, where the prophylactic methods to prevent PPH differed: oxytocin (5 IU IV) versus carbetocin (100 μg IV) given immediately after vaginal delivery. High‐risk women were defined by at least one of the following criteria: previous PPH (blood loss ≥500 mL), antenatal suspicion of macrosomia (estimated fetal weight >90th p), twin pregnancy, repeated cervical ripening methods, polyhydramnios, multiparity (≥4), and rapid labor (
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Obstetrics and Gynecology, Centre Hospitalier Departemental, La Roche sur Yon, France.
- Clinical Research Center, Centre Hospitalier Departemental, La Roche sur Yon, France.
ORCID-Profile: Guillaume Ducarme
Zitieren
APA
Sauvee, M., Lefizelier, E., Ropers, L., Dimet, J., & Ducarme, G. (2026). Prophylactic carbetocin versus oxytocin following vaginal delivery among women with high risk for postpartum hemorrhage: A before‐and‐after study. Acta Obstetricia et Gynecologica Scandinavica, 105(5), 940-947. https://doi.org/10.1111/aogs.70180
Vancouver
Sauvee M, Lefizelier E, Ropers L, Dimet J, Ducarme G. Prophylactic carbetocin versus oxytocin following vaginal delivery among women with high risk for postpartum hemorrhage: A before‐and‐after study. Acta Obstetricia et Gynecologica Scandinavica. 2026;105(5):940-947. doi:10.1111/aogs.70180
BibTeX
@article{Sauvee2026,
author = {Sauvee, Margot and Lefizelier, Emelyne and Ropers, Louen and Dimet, Jerome and Ducarme, Guillaume},
title = {Prophylactic carbetocin versus oxytocin following vaginal delivery among women with high risk for postpartum hemorrhage: A before‐and‐after study},
journal = {Acta Obstetricia et Gynecologica Scandinavica},
year = {2026},
volume = {105},
number = {5},
pages = {940--947},
doi = {10.1111/aogs.70180}
}
EUVIMED